Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company seeks a turnaround

statnews.com/2025/05/16/lars-jorgensen-novo-nordisk-ceo-wegovy-ozempic

LONDON — Lars Fruergaard Jørgensen, who led Novo Nordisk as it rode the boom of its obesity and diabetes medications to become one of the biggest players in pharma, only to see that success stall in recent months, is stepping down as CEO, the company said Friday.
Jørgensen, who’s worked…

This story appeared on statnews.com, 2025-05-16 20:04:01.056000.
The Entire Business World on a Single Page. Free to Use →